[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
UK Confirms Indefinite Recognition of CE-Marked Medical Devices

UK Confirms Indefinite Recognition of CE-Marked Medical Devices

by Steven Hewison | Nov 4, 2026 | Blog, Medical Devices

The UK Government’s decision to confirm the indefinite recognition of CE-marked medical devices represents a significant development for the medical technology industry, providing manufacturers with greater regulatory certainty while helping to safeguard patient access to essential healthcare technologies across Great Britain.

HPRA Update for Medical Devices

HPRA Update for Medical Devices

by Claire Dugdale | Mar 25, 2026 | Blog, Medical Devices

HPRA have today (23rd March 2026) released their latest update and the Mandatory Use of EUDAMED modules for medical devices

Recent Posts

  • UK Confirms Indefinite Recognition of CE-Marked Medical Devices
  • Minister responsible for Pharmacy announced
  • Heatwaves, Medicines and the Leadership Imperative

Upcoming Courses

  • GDP/RP Cogent Gold Standard Online Training on 17 November 2026
  • Superintendent Pharmacist training (Online) on 25 November 2026
  • RP Forum – tbc on 1 December 2026 10:00 am
  • GDP Audit Online Training on 7 December 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 8 December 2026 10:00 am

MHRA Alerts & Recalls

Class 4 Medicines Defect Notification: Star Pharmaceuticals Ltd, Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets, EL(26)A/48
12 November 2026
Field Safety Notices from 02 to 06 November2026.
10 November 2026
Class 4 Medicines Defect Notification: Sandoz Limited, Co-Amoxiclav powder for oral suspension 250/62.5 mg/5mL, EL(26)A/46
5 November 2026
Class 3 Medicines Recall: Aspire Pharma Limited, Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml , EL(26)A/47
5 November 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow